Clinical trial
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2…
NCT04809220 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT04809220 |
|---|---|
| Title | A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes |
| Official title | A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Two Doses of Dulaglutide in Combination With a Single Oral Antihyperglycemic Medication or as Monotherapy in Japanese Patients With Type 2 Diabetes Mellitus (AWARD-JPN: Assessment of Weekly Administration of LY2189265 in… |
| Acronym | AWARD-JPN |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Glucose Metabolism Disorders, Metabolic Disease, Endocrine System Diseases, Hypoglycemic Agents, Type 2 Diabetes Mellitus (T2DM) |
| Intervention type | Drug |
| Interventions | Dulaglutide, Oral antihyperglycemics |
| Enrollment | 591 |
| Start date | Apr 13, 2021 |
| Primary completion | Oct 1, 2022 |
| Completion | Apr 26, 2023 |
| First posted | Mar 22, 2021 |
| Last update posted | May 22, 2024 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: